BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Viyash Scientific Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
512529
ISIN Demat
INE807F01027
Book Value (Rs)
70.4015935
NSE Symbol
VIYASH
Divident Yield %
0
Market Cap
(Rs In Cr.)
11,581
P/E (TTM)
135.7
EPS (TTM)
1.94
Face Value
(Rs)
2
Back
Viyash Scientific consolidated net profit rises 107.07% in the June 2026 quarter
11-Aug-26   Hrs IST

Net profit of Viyash Scientific rose 107.07% to Rs 65.87 crore in the quarter ended June 2026 as against Rs 31.81 crore during the previous quarter ended June 2025. Sales rose 19.54% to Rs 946.36 crore in the quarter ended June 2026 as against Rs 791.64 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales946.36791.64 20
OPM %18.8515.00 -
PBDT174.18105.18 66
PBT112.4149.59 127
NP65.8731.81 107

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)